Abstract
Introduction/BackgroundAdjuvant treatment in endometrial carcinoma was based on classical risk stratification which included clinicopathological data. Molecular classification has been recently incorporated into risk stratification by ESGO guidelines. The aim of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Paper Title
Journal
Date
